Esolok 40 mg/vial (IV Injection)
40 mg vial: ৳ 100.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Esomeprazole |
| Company | Ibn sina pharmaceuticals ltd |
| Also available as |
Title
- Esolok 40 mg/vial Injection
Categories
- Medicine
- Gastroenterology
- Pharmacology
Description
- Proton pump inhibitor
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection
- Treatment of Zollinger-Ellison Syndrome
- Acid-related Dyspepsia relief
- Duodenal & Gastric ulcer treatment
Dimensions
- Vial size: 40 mg
Color options
- Clear solution
Functions
- Reduces gastric acid secretion
- Aids in healing esophageal damage caused by stomach acid
- Eradicates Helicobacter pylori infection
Materials
- Active ingredient: Esomeprazole
- Inactive ingredients: to be specified by manufacturer
Technical specifications
- Drug absorption time: 1.5 hours
- Metabolism by CYP2C19 and CYP3A4 enzymes
- Plasma protein binding: 97%
- Plasma elimination half-life: 1–1.5 hours
- Storage temperature: not exceeding 30°C
Design elements
- Enteric-coated pellet formulation
- Injection solution: clear and colorless to slightly yellow
Usability features
- Oral dosage form
- IV injection or IV infusion available
Dosage instructions
- 20 mg or 40 mg once daily for various conditions
- Dosage forms: tablet, capsule, oral suspension, IV injection
Administration
- Tablet or capsule: swallow whole and taken one hour before a meal
- Oral Suspension: to be thoroughly mixed with water and consumed within 30 minutes
- IV Injection: administered over a period of at least 3 minutes
Interaction
- Metabolism by CYP2C19 and CYP3A4 enzymes
- Potential interference with drug absorption due to gastric pH alteration
Contraindications
- Hypersensitivity to any of the formulation
Side effects
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy lactation
- No adequate and well-controlled studies in pregnant women
- No excretion of esomeprazole in milk studied
- Breastfeeding should be discontinued if esomeprazole use is essential
Precautions warnings
- Symptomatic response to therapy does not exclude gastric malignancy
- Instructions for patients with difficulty swallowing capsules
Use in special populations
- Safety and effectiveness not established in pediatric patients
- No observed differences in safety and efficacy between elderly and younger individuals
Overdose effects
- No specific antidote known
- Symptomatic and supportive treatment recommended
Storage conditions
- Store at a temperature not exceeding 30°C
- Protect from light and moisture
- Keep out of reach of children
Chemical structure
- Molecular Formula: C17H19N3O3S
Commonly asked questions
- What is Esolok 40 mg/vial Injection?
- What are the side effects of Esolok 40 mg/vial Injection?
- Can I take Esolok 40 mg/vial Injection if I am pregnant or breastfeeding?
- How long does it take for Esolok 40 mg/vial Injection to work?